N-BOC-β-cyclohexylalanine amide | 141408-67-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-BOC-β-cyclohexylalanine amide
• 英文别名: tert-butyl N-[(2S)-1-amino-3-cyclohexyl-1-oxopropan-2-yl]carbamate
• CAS: 141408-67-5
• 化学式: C₁₄H₂₆N₂O₃
• 分子量: 270.372
• InChiKey: YABONZSFQYECHS-NSHDSACASA-N

物化性质

• 沸点：
  438.2±28.0 °C(Predicted)
• 密度：
  1.053±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  19
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  81.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-BOC-β-cyclohexylalanine amide 在 lithium aluminium tetrahydride 作用下， 生成 2-甲基-2-丙基[(2S)-1-环己基-3-氧代-2-丙基]氨基甲酸酯
  参考文献：
  名称：

  Benz, Guenter; Henning, Rolf; Stasch, Johannes-Peter, Angewandte Chemie, 1991, vol. 103, # 12, p. 1735 - 1737

  摘要：

  DOI：
• 作为产物：
  描述：

  丁氧羰基--环乙基-丙氨酸-羟基盐酸盐 在 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 、 ammonium hydroxide 作用下， 以 二氯甲烷 为溶剂， 反应 0.33h， 生成 N-BOC-β-cyclohexylalanine amide
  参考文献：
  名称：

  RITA Mimics: Synthesis and Mechanistic Evaluation of Asymmetric Linked Trithiazoles

  摘要：

  The established cytotoxic agent RITA contains a thiophene-furan-thiophene backbone and two terminal alcohol groups. Herein we investigate the effect of using thiazoles as the backbone in RITA-like molecules and modifying the terminal groups of these trithiazoles, thereby generating 41 unique structures. Incorporating side chains with varied steric bulk allowed us to investigate how size and a stereocenter impacted biological activity. Subjecting compounds to growth inhibition assays on HCT-116 cells showed that the most potent compounds 7d, 7e, and 7h had GI₅₀ values of 4.4, 4.4, and 3.4 μM, respectively, versus RITA (GI₅₀ of 800 nM). Analysis of these compounds in apoptosis assays proved that 7d, 7e, and 7h were as effective as RITA at inducing apoptosis. Evaluating the impact of 7h on proteins targeted by RITA (p53, c-Myc, and Mcl-1) indicated that it acts via a different mechanism of action to that of RITA. RITA suppressed Mcl-1 protein via p53, whereas compound 7h suppressed Mcl-1 expression via an alternative mechanism independent of p53.

  DOI：

  10.1021/acsmedchemlett.6b00488

文献信息

• Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C
  作者：Daniel Guay、Christian Beaulieu、T. Jagadeeswar Reddy、Robert Zamboni、Nathalie Methot、Joel Rubin、Diane Ethier、M. David Percival

  DOI：10.1016/j.bmcl.2009.07.114

  日期：2009.9

  A series of dipeptide nitriles with a thienyl alanine in P2 were identified as potent and selective cathepsin C inhibitors. Incorporation of a substituted cyclopropyl moiety in P1 effectively protects these derivatives against hydrolase activity in whole blood.

  一系列在P2中带有噻吩丙氨酸的二肽腈被确定为有效的和选择性的组织蛋白酶C抑制剂。在P1中引入取代的环丙基部分可有效保护这些衍生物免于全血中的水解酶活性。
• Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
  申请人：Rhone-Poulenc Rorer Pharmaceuticals Inc.

  公开号：US05866685A1

  公开（公告）日：1999-02-02

  The present invention relates to azacycloalkylalkanoyl peptides and pseudopeptides which inhibit platelet aggregation and thrombus formation thereby being useful in the prevention and treatment of thrombosis associated with disease states such as myocardial infarction, stroke, peripheral arterial disease, and disseminated intravascular coagulation, to methods for the prevention or treatment of thrombosis in a mammal in need of such therapy comprising the administration of a therapeutically effective amount of such compounds, and to pharmaceutical compositions comprising such compounds.

  本发明涉及抑制血小板聚集和血栓形成的氮杂环烷基酰基肽和伪肽，因此在预防和治疗与疾病状态相关的血栓形成，如心肌梗死、中风、周围动脉疾病和弥散性血管内凝血等方面具有用途，以及用于在需要此类治疗的哺乳动物中预防或治疗血栓形成的方法，包括给予这些化合物的治疗有效量，以及包含这些化合物的药物组合物。
• [EN] ANTITHROMBOTIC AZACYCLOALKYLALKANOYL PEPTIDES AND PSEUDOPEPTIDES<br/>[FR] PEPTIDES ET PSEUDOPEPTIDES A GROUPE AZACYCLOALKYLALCANOYLE AYANT DES PROPRIETES ANTITHROMBOTIQUES
  申请人：RHONE-POULENC RORER PHARMACEUTICALS INC.

  公开号：WO1995010295A1

  公开（公告）日：1995-04-20

  (EN) The present invention relates to azacycloalkylalkanoyl peptides and pseudopeptides which inhibit platelet aggregation and thrombus formation thereby being useful in the prevention and treatment of thrombosis associated with disease states such as myocardial infarction, stroke, peripheral arterial disease, and disseminated intravascular coagulation, to methods for the prevention or treatment of thrombosis in a mammal in need of such therapy comprising the administration of a therapeutically effective amount of such compounds, and to pharmaceutical compositions comprising such compounds.(FR) La présente invention concerne des peptides ou pseudopeptides à groupe azacycloalkylalcanoyle qui inhibent l'agrégation plaquettaire et la formation de thrombus, ce qui les rend utiles dans la prévention et le traitement de thromboses que l'on rencontre dans des états pathologiques tels que l'infarctus du myocarde, les accidents cérébrovasculaires, les maladies vasculaires périphériques, et la coagulation intravasculaire disséminée. L'invention concerne également des méthodes de prévention ou de traitement de thromboses chez des mammifères nécessitant une telle thérapie, consistant à d'administrer une dose appropriée de tels composés, ainsi que des compositions pharmaceutiques comprenant de tels composés.

  本发明涉及抑制血小板聚集和血栓形成的氮杂环烷基烷酰肽和假肽，因此可用于预防和治疗与疾病状态相关的血栓形成，如心肌梗死、中风、外周动脉疾病和弥漫性血管内凝血，以及用于治疗需要此类治疗的哺乳动物的预防或治疗血栓形成的方法，包括给予这些化合物的治疗有效量，以及包含这些化合物的制药组合物。
• Design, synthesis and biological evaluation of peptide derivatives of l-dopa as anti-parkinsonian agents
  作者：Tao Zhou、Robert C. Hider、Peter Jenner、Bruce Campbell、Christopher J. Hobbs、Sarah Rose、Mark Jairaj、Kayhan A. Tayarani-Binazir、Alexander Syme

  DOI：10.1016/j.bmcl.2013.08.007

  日期：2013.10

  A series of dipeptide derivatives of L-dopa were synthesized and investigated for their pharmacological activity using the unilaterally 6-hydroxydopamine (6-OHDA)-lesioned rat as an experimental model of Parkinson's disease. Among them, (S)-isopropyl 2-(2-amino-2-methylpropanamido)-3-(3,4-dihydroxyphenyl) propanoate (4g) was found to be the most active compound, with 106% AUC activity and 149% peak activity of L-dopa after oral administration. (C) 2013 Elsevier Ltd. All rights reserved.
• From garden to lab: C-3 chemical modifications of tomatidine unveil broad-spectrum ATP synthase inhibitors to combat bacterial resistance
  作者：Julien A. Delbrouck、Alexandre Murza、Iryna Diachenko、Abdelkhalek Ben Jamaa、Runjun Devi、Audrey Larose、Suzanne Chamberland、François Malouin、Pierre-Luc Boudreault

  DOI：10.1016/j.ejmech.2023.115886

  日期：2023.12